F. Hoffmann-La Roche Ltd - China National Drug Administration grants rapid approval of Roche's Alecensa (alectinib) as a treatment for ALK-positive lung cancer
F. Hoffmann-La Roche Ltd / China National Drug Administration grants rapid approval of Roche's Alecensa (alectinib) as a treatment for ALK-positive lung cancer ...Articles similaires à F. Hoffmann-La Roche Ltd - China National Drug Administration grants rapid approval of Roche's Alecensa (alectinib) as a treatment for ALK-positive lung cancer
• Sources :
• Mots clés :
• Participer :
• Suivre l'actualité :
BACK TO TOP
